Assertio Therapeutics Announces Closing of Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million
LAKE FOREST, Ill., Feb. 13, 2020 (GLOBE NEWSWIRE) — Assertio Therapeutics, Inc. (“Assertio” or “The Company”) (NASDAQ: ASRT), today announced […]